drugset / Trial / NCT02475421
Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance
Completed
32 enrolled
University Hospital, Gentofte, Copenhagen
European Foundation for the Study of Diabetes · collabUniversity of Copenhagen · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The study aims to evaluate the elimination and degradation of glucagon in patients with type 2 diabetes compared to matched healthy subjects.
Timeline
- Start
- 2015-05
- Primary completion
- 2016-12
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucagon | Peptide | — | — |